PMID: 7109646May 1, 1982Paper

Radioimmunoassay techniques for the determination of the local release of prostaglandins and thromboxanes

Journal of Pharmacological Methods
S J CokerI J Zeitlin


Radioimmunoassay techniques are described that enable the quantification of the local release of prostaglandin (PG) E2, PGF2 alpha, TxB2 (the metabolite of thromboxane A2), and 6-keto PGF1 alpha (a metabolite of prostacyclin) from various organs in vivo. Plasma samples were acidified and the prostanoids extracted with ethyl acetate, prior to assay. The mean recovery of tritiated internal standards was 60% for 6-keto PGF1 alpha and 84% for the other prostanoids. Sample extracts were redissolved in phosphate-buffered saline and the appropriate tritiated antigen and specific antibody were added. After overnight incubation the antibody-bound and free prostanoid were separated using dextran-coated charcoal. The intraassay variation and the interassay variation were similar for all prostanoids; the mean values being 8.5% and 13.2%, respectively. There were variations in the sensitivity of the radioimmunoassay for each prostanoid. Using 250 microliter plasma samples the detection limit for PGE2 was 75 pg/ml, PGF2 alpha 50 pg/ml, TxB2 25 pg/ml, and 6-keto PGF1 alpha 125 pg/ml. These assays have been used to determine prostanoid concentrations in rats, cats, dogs, and humans.


Apr 1, 1979·Prostaglandins and Medicine·R I LewyL Wiener
Jan 1, 1978·Prostaglandins·E Granström
Jun 1, 1976·Journal of Steroid Biochemistry·B SeatonJ Watson
Jul 29, 1975·European Journal of Clinical Investigation·F DrayJ Maclouf
Aug 1, 1971·The American Journal of Medicine·G C OliverC W Parker
Dec 1, 1971·The Journal of Clinical Endocrinology and Metabolism·J VaitukaitisG T Ross
Feb 5, 1971·Science·B M JaffeC W Parker
Aug 1, 1971·The Journal of Clinical Endocrinology and Metabolism·B V CaldwellL Speroff
Mar 1, 1980·Canadian Journal of Physiology and Pharmacology·E F SmithJ B Smith

❮ Previous
Next ❯


Jan 1, 1987·Pediatric Cardiology·C HammermanK C Bui
Jan 1, 1986·Pediatric Cardiology·C HammermanA Aldousany
Jan 1, 1986·Pediatric Cardiology·C HammermanS Valaitis
Apr 1, 1994·Prostaglandins·A SalaG Folco
Aug 1, 1982·Prostaglandins, Leukotrienes, and Medicine·T J CartyT K Schaaf
Mar 1, 1984·Prostaglandins, Leukotrienes, and Medicine·E SchrauwenA Houvenaghel
Sep 1, 1985·Prostaglandins, Leukotrienes, and Medicine·I A GreerC D Forbes
Feb 19, 2000·Prostaglandins & Other Lipid Mediators·S C TrompM G oude Egbrink
Feb 1, 1996·Journal of Veterinary Pharmacology and Therapeutics·A J GuthrieJ P Nurton
Nov 1, 1990·The Journal of Pediatrics·C Hammerman, M J Aramburo
Aug 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·C HammermanV Hill
May 1, 1984·British Journal of Pharmacology·J R ParrattI J Zeitlin
Sep 1, 1987·British Journal of Pharmacology·G AutoreN Mascolo
Dec 1, 1988·The Journal of Pediatrics·C Hammerman, M J Aramburo
Jul 15, 1986·Klinische Wochenschrift·F J Krause

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.